Aryndan Health & Care Limited 08435025 false 2025-04-01 2026-03-31 2026-03-31 The principal activity of the company is that of the provision of general medical services and healthcare. Digita Accounts Production Advanced 6.30.9574.0 true 08435025 2025-04-01 2026-03-31 08435025 2026-03-31 08435025 core:CurrentFinancialInstruments 2026-03-31 08435025 core:CurrentFinancialInstruments core:WithinOneYear 2026-03-31 08435025 core:Non-currentFinancialInstruments core:AfterOneYear 2026-03-31 08435025 core:OfficeEquipment 2026-03-31 08435025 core:PlantMachinery 2026-03-31 08435025 bus:SmallEntities 2025-04-01 2026-03-31 08435025 bus:AuditExemptWithAccountantsReport 2025-04-01 2026-03-31 08435025 bus:FilletedAccounts 2025-04-01 2026-03-31 08435025 bus:SmallCompaniesRegimeForAccounts 2025-04-01 2026-03-31 08435025 bus:RegisteredOffice 2025-04-01 2026-03-31 08435025 bus:Director1 2025-04-01 2026-03-31 08435025 bus:PrivateLimitedCompanyLtd 2025-04-01 2026-03-31 08435025 core:OfficeEquipment 2025-04-01 2026-03-31 08435025 core:PlantMachinery 2025-04-01 2026-03-31 08435025 countries:England 2025-04-01 2026-03-31 08435025 2025-03-31 08435025 core:OfficeEquipment 2025-03-31 08435025 core:PlantMachinery 2025-03-31 08435025 2024-04-01 2025-03-31 08435025 2025-03-31 08435025 core:CurrentFinancialInstruments 2025-03-31 08435025 core:CurrentFinancialInstruments core:WithinOneYear 2025-03-31 08435025 core:Non-currentFinancialInstruments core:AfterOneYear 2025-03-31 08435025 core:OfficeEquipment 2025-03-31 08435025 core:PlantMachinery 2025-03-31 iso4217:GBP xbrli:pure

Registration number: 08435025

Aryndan Health & Care Limited

Unaudited Filleted Abridged Financial Statements

for the Year Ended 31 March 2026

 

Aryndan Health & Care Limited

Contents

Abridged Balance Sheet

1 to 2

Notes to the Unaudited Abridged Financial Statements

3 to 4

 

Aryndan Health & Care Limited

(Registration number: 08435025)
Abridged Balance Sheet as at 31 March 2026

Note

2026
£

2025
£

Fixed assets

 

Tangible assets

4

1,694

2,116

Current assets

 

Debtors

476,291

31,709

Cash at bank and in hand

 

95,373

177,826

 

571,664

209,535

Prepayments and accrued income

 

7,276

6,902

Creditors: Amounts falling due within one year

(44,059)

(17,333)

Net current assets

 

534,881

199,104

Total assets less current liabilities

 

536,575

201,220

Creditors: Amounts falling due after more than one year

(282,664)

-

Provisions for liabilities

(322)

(402)

Accruals and deferred income

 

(3,744)

(3,600)

Net assets

 

249,845

197,218

Capital and reserves

 

Called up share capital

100

100

Retained earnings

249,745

197,118

Shareholders' funds

 

249,845

197,218

For the financial year ending 31 March 2026 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Directors' responsibilities:

•

The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476; and

•

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

All of the company’s members have consented to the preparation of an Abridged Balance Sheet in accordance with Section 444(2A) of the Companies Act 2006.

These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime. As permitted by section 444 (5A) of the Companies Act 2006, the directors have not delivered to the registrar a copy of the Profit and Loss Account.

Approved and authorised by the Board on 12 June 2026 and signed on its behalf by:
 

 

Aryndan Health & Care Limited

(Registration number: 08435025)
Abridged Balance Sheet as at 31 March 2026

.........................................
Dr Vijay Sangar
Director

 

Aryndan Health & Care Limited

Notes to the Unaudited Abridged Financial Statements for the Year Ended 31 March 2026

1

General information

The company is a private company limited by share capital, incorporated in England.

The address of its registered office is:
Trinity Chambers
8 Suez Street
Warrington
Cheshire
WA1 1EG
England

These financial statements were authorised for issue by the Board on 12 June 2026.

2

Accounting policies

Summary of significant accounting policies and key accounting estimates

The principal accounting policies applied in the preparation of these financial statements are set out below. These policies have been consistently applied to all the years presented, unless otherwise stated.

Statement of compliance

These abridged financial statements have been prepared in accordance with Financial Reporting Standard 102 Section 1A smaller entities - 'The Financial Reporting Standard applicable in the United Kingdom and Republic of Ireland' and the Companies Act 2006 (as applicable to companies subject to the small companies' regime).

Basis of preparation

These abridged financial statements have been prepared using the historical cost convention except that as disclosed in the accounting policies certain items are shown at fair value.

Revenue recognition

Turnover comprises the fair value of the consideration received or receivable for the sale of goods and provision of services in the ordinary course of the company’s activities. Turnover is shown net of sales/value added tax, returns, rebates and discounts.

The company recognises revenue when:
The amount of revenue can be reliably measured;
it is probable that future economic benefits will flow to the entity;
and specific criteria have been met for each of the company's activities.

Tax

The tax expense for the period comprises current and deferred tax. Tax is recognised in profit or loss, except that a change attributable to an item of income or expense recognised as other comprehensive income is also recognised directly in other comprehensive income.

The current income tax charge is calculated on the basis of tax rates and laws that have been enacted or substantively enacted by the reporting date in the countries where the company operates and generates taxable income.

 

Aryndan Health & Care Limited

Notes to the Unaudited Abridged Financial Statements for the Year Ended 31 March 2026

Deferred tax is recognised in respect of all timing differences between taxable profits and profits reported in the financial statements.

Unrelieved tax losses and other deferred tax assets are recognised when it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Deferred tax is measured using the tax rates and laws that have been enacted or substantively enacted by the reporting date and that are expected to apply to the reversal of the timing difference.

Tangible assets

Tangible assets are stated in the balance sheet at cost, less any subsequent accumulated depreciation and subsequent accumulated impairment losses.

The cost of tangible assets includes directly attributable incremental costs incurred in their acquisition and installation.

Depreciation

Depreciation is charged so as to write off the cost of assets, other than land and properties under construction over their estimated useful lives, as follows:

3

Staff numbers

The average number of persons employed by the company (including directors) during the year, was 3 (2025 - 3).

4

Tangible assets

Plant and machinery
£

Office equipment
£

Total
£

Cost or valuation

At 1 April 2025

601

7,548

8,149

At 31 March 2026

601

7,548

8,149

Depreciation

At 1 April 2025

559

5,474

6,033

Charge for the year

8

414

422

At 31 March 2026

567

5,888

6,455

Carrying amount

At 31 March 2026

34

1,660

1,694

At 31 March 2025

42

2,074

2,116